MedTrace Logo

Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes

NCT04501991 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2020-08-06

No results posted yet for this study

Summary

The strict rules applied in Italy during the recent COVID-19 pandemic, with the prohibition to attend any regular outdoor activity, are likely to influence the degree of metabolic control of patients with type 2 diabetes. The aim of this observational, prospective, single centre study was to evaluate the immediate impact of the lockdown rules on the metabolic profile of a cohort of patients with type 2 diabetes.

Conditions

Interventions

OTHER

antidiabetic treatment

Every kind of antidiabetic treatment, oral or injective, were considered including patients treated only with diet

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Principal Investigators

  • Anna Solini, MD, PhD · University of Pisa

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-11
Primary Completion
2020-05-04
Completion
2020-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04501991 on ClinicalTrials.gov